Dupilumab-associated ocular surface disease in atopic dermatitis: a large prospective cohort study from the BioDay registry.
PURPOSE Dupilumab-associated ocular surface disease (DAOSD) is a frequently reported side effect in atopic dermatitis (AD) patients treated with dupilumab. This study aimed to investigate the frequency and severity of DAOSD, the effect of ophthalmic treatment on (DA)OSD, and the effect of dupilumab on conjunctival gobl...